CA1070612A - Methode d'immunofluorescence en phase solide - Google Patents

Methode d'immunofluorescence en phase solide

Info

Publication number: CA1070612A
Authority: CA; Canada
Prior art keywords: unknown; particles; antigen; antibody; immune reactant
Prior art date: 1975-10-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA255,623A

Other languages

English (en)

Inventor

Robert V. Dahlstrom

Michael W. Burgett

James F. Monthony

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bio Rad Laboratories Inc

Original Assignee

Bio Rad Laboratories Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-10-09

Filing date

1976-06-24

Publication date

1980-01-29

1976-06-24 Application filed by Bio Rad Laboratories Inc filed Critical Bio Rad Laboratories Inc

1980-01-29 Application granted granted Critical

1980-01-29 Publication of CA1070612A publication Critical patent/CA1070612A/fr

Status Expired legal-status Critical Current

Links

238000003556 assay Methods 0.000 title claims abstract description 46
239000007790 solid phase Substances 0.000 title abstract description 4
239000000427 antigen Substances 0.000 claims abstract description 91
102000036639 antigens Human genes 0.000 claims abstract description 89
108091007433 antigens Proteins 0.000 claims abstract description 89
239000002245 particle Substances 0.000 claims abstract description 83
239000000376 reactant Substances 0.000 claims abstract description 74
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
229910001868 water Inorganic materials 0.000 claims abstract description 9
238000005259 measurement Methods 0.000 claims abstract description 5
238000000926 separation method Methods 0.000 claims abstract description 3
239000007864 aqueous solution Substances 0.000 claims description 12
238000006243 chemical reaction Methods 0.000 claims description 12
239000012530 fluid Substances 0.000 claims description 11
230000027455 binding Effects 0.000 claims description 9
239000000725 suspension Substances 0.000 claims description 9
230000001900 immune effect Effects 0.000 claims description 8
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 7
229920002401 polyacrylamide Polymers 0.000 claims description 7
239000007900 aqueous suspension Substances 0.000 claims description 6
239000007795 chemical reaction product Substances 0.000 claims 1
238000010166 immunofluorescence Methods 0.000 claims 1
238000000034 method Methods 0.000 abstract description 30
102000004169 proteins and genes Human genes 0.000 abstract description 8
108090000623 proteins and genes Proteins 0.000 abstract description 8
229920001184 polypeptide Polymers 0.000 abstract description 4
102000004196 processed proteins & peptides Human genes 0.000 abstract description 4
108090000765 processed proteins & peptides Proteins 0.000 abstract description 4
101710100170 Unknown protein Proteins 0.000 abstract 1
239000012295 chemical reaction liquid Substances 0.000 abstract 1
239000011324 bead Substances 0.000 description 63
239000000523 sample Substances 0.000 description 13
210000002966 serum Anatomy 0.000 description 12
239000006228 supernatant Substances 0.000 description 8
238000012360 testing method Methods 0.000 description 8
241000283973 Oryctolagus cuniculus Species 0.000 description 7
239000000203 mixture Substances 0.000 description 7
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
239000008363 phosphate buffer Substances 0.000 description 5
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
238000000386 microscopy Methods 0.000 description 4
241000894007 species Species 0.000 description 4
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 3
229920000936 Agarose Polymers 0.000 description 3
102000006395 Globulins Human genes 0.000 description 3
108010044091 Globulins Proteins 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
239000000872 buffer Substances 0.000 description 3
230000002285 radioactive effect Effects 0.000 description 3
241000283707 Capra Species 0.000 description 2
XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
238000013459 approach Methods 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
238000012875 competitive assay Methods 0.000 description 2
230000009137 competitive binding Effects 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000001514 detection method Methods 0.000 description 2
230000005284 excitation Effects 0.000 description 2
238000005558 fluorometry Methods 0.000 description 2
229960004198 guanidine Drugs 0.000 description 2
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
208000006454 hepatitis Diseases 0.000 description 2
231100000283 hepatitis Toxicity 0.000 description 2
239000008188 pellet Substances 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
239000000700 radioactive tracer Substances 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000012800 visualization Methods 0.000 description 2
229920003176 water-insoluble polymer Polymers 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
IGHBXJSNZCFXNK-UHFFFAOYSA-N 4-chloro-7-nitrobenzofurazan Chemical compound [O-][N+](=O)C1=CC=C(Cl)C2=NON=C12 IGHBXJSNZCFXNK-UHFFFAOYSA-N 0.000 description 1
XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
241000489861 Maximus Species 0.000 description 1
241000609499 Palicourea Species 0.000 description 1
101710151715 Protein 7 Proteins 0.000 description 1
-1 Rhodamine B isothiocyanate Chemical class 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
101710123661 Venom allergen 5 Proteins 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000002532 anti-gammaglobulin Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000012496 blank sample Substances 0.000 description 1
150000007942 carboxylates Chemical class 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000013068 control sample Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
230000000093 cytochemical effect Effects 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
230000000694 effects Effects 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
239000011325 microbead Substances 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
239000011148 porous material Substances 0.000 description 1
150000003141 primary amines Chemical group 0.000 description 1
230000008569 process Effects 0.000 description 1
239000012460 protein solution Substances 0.000 description 1
230000004044 response Effects 0.000 description 1
229940043267 rhodamine b Drugs 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229920001897 terpolymer Polymers 0.000 description 1
229940034208 thyroxine Drugs 0.000 description 1
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
238000004448 titration Methods 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

CA255,623A 1975-10-09 1976-06-24 Methode d'immunofluorescence en phase solide Expired CA1070612A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US62119775A	1975-10-09	1975-10-09

Publications (1)

Publication Number	Publication Date
CA1070612A true CA1070612A (fr)	1980-01-29

Family

ID=24489155

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA255,623A Expired CA1070612A (fr)	1975-10-09	1976-06-24	Methode d'immunofluorescence en phase solide

Country Status (7)

Country	Link
JP (1)	JPS6010578B2 (fr)
BR (1)	BR7605664A (fr)
CA (1)	CA1070612A (fr)
DE (1)	DE2641713A1 (fr)
FR (1)	FR2327546A1 (fr)
GB (1)	GB1552374A (fr)
IT (1)	IT1066186B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1111762A (fr) *	1977-12-28	1981-11-03	David S. Frank	Chelate de terre rare fluorescent dans des particules de latex polymerique
US4171311A (en) *	1978-01-16	1979-10-16	International Diagnostics Tech. Inc.	Imides of thyroxin and triiodothyronine
EP0030087A1 (fr) *	1979-11-13	1981-06-10	Technicon Instruments Company Limited	Procédé et dispositif d'immuno-essais et trousse pour mise en oeuvre de ce procédé
DE3132491A1 (de) *	1980-08-22	1982-07-01	Laboratorium Prof. Dr. Rudolf Berthold, 7547 Wildbad	Verfahren zur durchfuehrung analytischer bestimmungen mittels der chemilumineszenzmethode und anwendung des verfahrens fuer immunassays
IT1140209B (it) *	1981-09-25	1986-09-24	Anic Spa	Reagenti per immunoluorescenza e metodo per la loro preparazione
JPS59108111U (ja) *	1983-01-10	1984-07-20	ダイキン工業株式会社	貯湯式給湯機
JPS59220271A (ja) *	1983-05-27	1984-12-11	Kawasaki Heavy Ind Ltd	複合材の鋳造法
GB8401368D0 (en) *	1984-01-19	1984-02-22	Amersham Int Plc	Assay method
CN111007241A (zh) *	2019-12-20	2020-04-14	苏州和迈精密仪器有限公司	基于双层多孔膜的荧光竞争法免疫检测方法、装置及应用

1976
- 1976-06-24 CA CA255,623A patent/CA1070612A/fr not_active Expired
- 1976-07-06 GB GB2810576A patent/GB1552374A/en not_active Expired
- 1976-07-23 FR FR7622676A patent/FR2327546A1/fr active Granted
- 1976-08-27 BR BR7605664A patent/BR7605664A/pt unknown
- 1976-09-10 JP JP10868176A patent/JPS6010578B2/ja not_active Expired
- 1976-09-16 DE DE19762641713 patent/DE2641713A1/de not_active Withdrawn
- 1976-09-17 IT IT5133076A patent/IT1066186B/it active

Also Published As

Publication number	Publication date
JPS6010578B2 (ja)	1985-03-18
JPS5246884A (en)	1977-04-14
GB1552374A (en)	1979-09-12
BR7605664A (pt)	1977-08-23
FR2327546A1 (fr)	1977-05-06
FR2327546B3 (fr)	1979-04-13
DE2641713A1 (de)	1977-04-21
IT1066186B (it)	1985-03-04

Legal Events

Date	Code	Title	Description
1997-01-29	MKEX	Expiry

Publication	Publication Date	Title
US4254096A (en)	1981-03-03	Reagent combination for solid phase immunofluorescent assay
US4201763A (en)	1980-05-06	Solid phase immunofluorescent assay method
EP0201079B1 (fr)	1996-04-17	Essai immunologique retardé en phase solide
US4506009A (en)	1985-03-19	Heterogeneous immunoassay method
US4289747A (en)	1981-09-15	Immunological determination using lectin
US4925788A (en)	1990-05-15	Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor
US4185084A (en)	1980-01-22	Immunochemical measuring method using second antigenic substance
CA1200482A (fr)	1986-02-11	Conjugat de deux anticorps
US6303325B1 (en)	2001-10-16	Method for detecting analytes
JPH0340341B2 (fr)	1991-06-18
JP2636331B2 (ja)	1997-07-30	抗原特異的な抗体の一段階測定法およびそれに適する試薬
US5650333A (en)	1997-07-22	Immunoassay method and kit using superaggregated complex
US5362655A (en)	1994-11-08	Process for the determination of a specifically bindable substance
JPS6338667B2 (fr)	1988-08-01
US4088746A (en)	1978-05-09	Radioimmunoassay for thyroid-stimulating hormone (TSH)
CA1070612A (fr)	1980-01-29	Methode d'immunofluorescence en phase solide
CA1146853A (fr)	1983-05-24	Methode pour adsorber passivement des haptenes immuno-reactifs a des supports solides
JPH1078435A (ja)	1998-03-24	被検物質の免疫化学的測定における感度の上昇
JP2736058B2 (ja)	1998-04-02	免疫検定用器具の製造方法
CA2002470A1 (fr)	1990-05-10	Methode de depistage d'antigenes
EP0308235B1 (fr)	1992-07-22	Fixation de composés à des particules polymères en utilisant des composés carbamoylonium
CA2169121C (fr)	2007-07-03	Immuno-essai par competition, utilisant des derives de produits a analyser transformes en complexes
EP0389301A2 (fr)	1990-09-26	Complexe réactif pour l'essai immunologique
WO1984003358A1 (fr)	1984-08-30	Surfaces insolubles traitees pour inhiber la liaison d'une proteine non-specifique
US5989922A (en)	1999-11-23	Method for determining rheumatoid factors and agents for carrying out the method